SCHEMBL6826259

SCHEMBL6826259

O=C(O)CNCCCC(Oc1cccc(C(=O)c2ccncc2)c1)c1ccc(F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.39
LTA4H P09960 1/20 0.39
KMT2A Q03164 3/20 0.37
EPHX2 P34913 1/20 0.37
SLC6A9 P48067 3/20 0.37
VNN1 O95497 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP2D6 P10635 1/20 0.37
MAPT P10636 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
SLC6A5 Q9Y345 1/20 0.37
SLC6A2 P23975 1/20 0.36
CACNA2D1 P54289 1/20 0.36
ABCB1 P08183 2/20 0.35
LMNA P02545 1/20 0.35
ALPG P10696 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6826264 0.91 SLC6A4 (0.39) SLC6A4LTA4HKMT2ASLC6A9SLC6A2
SCHEMBL6826640 0.90 LTA4H (0.45) SLC6A4LTA4HKMT2ASLC6A9ALDH1A1
SCHEMBL6823045 0.81 SLC6A4 (0.41) SLC6A4LTA4HKMT2ASLC6A9GCGR
SCHEMBL7214342 0.79 SLC6A4 (0.45) SLC6A4SLC6A9ALDH1A1CYP2D6MAPT
SCHEMBL6826258 0.79 SLC6A9 (0.62) SLC6A9ALDH1A1CYP2D6MAPTCYP2C9
SCHEMBL6826677 0.79 SLC6A4 (0.43) SLC6A4LTA4HKMT2ASLC6A9ALDH1A1
SCHEMBL6826424 0.76 GCGR (0.38) SLC6A4SLC6A9ALDH1A1CYP2D6MAPT
SCHEMBL7208064 0.73 SLC6A4 (0.46) SLC6A4LTA4HSLC6A9HPGDGCGR
SCHEMBL6753047 0.73 SLC7A5 (0.41) SLC6A4KMT2ASLC6A9ALDH1A1CYP2D6
SCHEMBL6256697 0.73 SLC6A9 (0.42) SLC6A4KMT2ASLC6A9ALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1294677-B1 BENZOPHENONES AND SULFONES AS INHIBITORS OF GLYCINE UPTAKE PFIZER PROD INC (US) 2004-11-03 EP disclosed
EP-1294677-A1 BENZOPHENONES AND SULFONES AS INHIBITORS OF GLYCINE UPTAKE Pfizer Products Inc. (US) 2003-03-26 EP disclosed
US-6506780-B2 Benzophenones and sulfones as inhibitors of glycine uptake PFIZER INC. 2003-01-14 US disclosed
US-20020052401-A1 Benzophenones and sulfones as inhibitors of glycine uptake PFIZER INC. 2002-05-02 US disclosed
WO-2002000602-A1 BENZOPHENONES AND SULFONES AS INHIBITORS OF GLYCINE UPTAKE PFIZER PRODUCTS INC. (US) 2002-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020052401-A1 Benzophenones and sulfones as inhibitors of glycine uptake SLC6A1, SLC6A5, SLC1A2 SLC6A4 7/4885LTA4H 4297/4885KMT2A 1450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.